Citations

Clear

3138 citation(s) found for "Smith, AM".

Higher intraoperative plasma transfusion volumes are associated with inferior perioperative outcomes
Frank, Ryan D. , Weister, Timothy J. , Stubbs, James R. , Kor, Daryl J. , Smith, Mark M. , Warner, Matthew A.

Mayo Clinic

Transfusion | November 1, 2018 | Volume: 59 | Issue: 1 | Pages: 112-124

10.1111/trf.14988 | PMID 30383908 Get It

BACKGROUNDIntraoperative plasma transfusion is common, yet little is known regarding its effects on perioperative coagulation tests or clinical outcomes.STUDY DESIGN AND METHODSThis is a retrospective cohort study of adults receiving intraoperative plasma transfusion at a single center from 2011 to 2015. Relationships between plasma transfusion volume, changes in coagulation test values, and clinical outcomes, including a primary outcome of early postoperative red blood cell (RBC) transfusion, were assessed with multivariable regression analyses. Secondary outcomes included hospital mortality, intensive care unit (ICU)‐ and hospital‐free days, intraoperative RBC transfusions, and estimated blood loss.RESULTSA total of 3393 unique patients were included, with median (IQR) transfusion of 2 (2‐4) units. In multivariable analyses, higher plasma volumes were associated with worse outcomes, with each 1 mL/kg increase associated with increased odds for postoperative (1.02 [1.01‐1.03], p < 0.001) and intraoperative RBCs (1.17 [1.16‐1.19], p < 0.001) and fewer ICU‐ and hospital‐free days (mean difference [95% CI], –0.08 [−0.12 to −0.05], p < 0.001; and −0.09 [−0.13 to −0.06], p < 0.001, respectively). Greater decreases in international normalized ratio (INR) following plasma transfusion were associated with decreased odds of postoperative RBCs (0.35 [0.25‐0.47], p < 0.001), decreased mortality (0.50 [0.31‐0.83], p = 0.007), and increased mean ICU‐ (1.31 [0.41‐2.21], p = 0.004) and hospital‐free days (1.15 [0.19‐2.10], p = 0.018).CONCLUSIONIn patients receiving intraoperative plasma transfusion, higher transfusion volumes were associated with inferior clinical outcomes; however, greater improvements in INR were associated with improved outcomes. Future prospective studies are necessary to better define these relationships and to explore plasma transfusion triggers beyond the limitations of INR.
Isokinetic and isometric shoulder rotation strength in the protracted position: A reliability study
Smith, Jay , Padgett, Denny J., Kotajarvi, Brian R., Eischen, Joseph J.

Mayo Clinic

Isokinetics and Exercise Science | October 30, 2018 | Volume: 9 | Issue: 2-3 | Pages: 119-127

10.3233/ies-2001-0075 Get It

Scapular position has been hypothesized to influence rotator cuff function, but no current methods exist to reliably measure shoulder rotation strength in different scapular positions. The purpose of this study was to develop a reliable technique to measure isokinetic (ISOK) and isometric (ISOM) shoulder rotation strength with the scapula protracted. Ten healthy volunteers(5 male, 5 female, ages 20--41) completed two to three ISOM and five ISOK (90 degrees/second) internal rotation (IR) and external rotation (ER) repetitions in a position of scapular protraction with the shoulder abducted 45 degrees in the scapular plane. Subjects returned 24--72 hours later to repeat testing. All torque measurements in the protracted position exhibited excellent intersession reliability (ICCs > 0.97). Shoulder rotational torque can be measured in the protracted scapula position with excellent reliability using the new technique described. Establishing the reliability of the protracted technique is a necessary prerequisite for the completion of future studies examining quantitative differences in rotational torque generation between the neutral and protracted scapula positions in the functional shoulder position of 45 degrees of scapular plane abduction.
Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study
Adams, Charleen D. , Richmond, Rebecca C. , Ferreira, Diana L. Santos , Spiller, Wes , Tan, Vanessa Y. , Würtz, Peter , Donovan, Jenny , Hamdy, Freddie C. , Neal, David E. , Lane, J. Athene , Smith, George Davey , Relton, Caroline L. , Eeles, Rosalind A. , Haiman, Christopher A. , Schumacher, Fredrick R. , Olama, Ali Amin Al , Benlloch, Sara, Muir, Kenneth , Berndt, Sonja I., Conti, David V. , Gapstur, Susan M. , Stevens, Victoria L. , Batra, Jyotsna , Grönberg, Henrik , Pashayan, Nora , Schleutker, Johanna , West, Catharine , Mucci, Lorelei A. , Koutros, Stella , Sørensen, Karina D. , Mæhle, Lovise, Travis, Ruth C. , Rosenstein, Barry S. , Lu, Yong‐Jie , Kibel, Adam S. , Vega, Ana , Stanford, Janet L. , Nordestgaard, Børge G. , Maier, Christiane, Kim, Jeri , John, Esther M. , Teixeira, Manuel R. , Newcomb, Lisa F., Lessel, Davor , Kaneva, Radka , Usmani, Nawaid , Claessens, Frank , Townsend, Paul A. , Dominguez, Manuela Gago, Roobol, Monique J. , Ménégaux, F. , Pandha, Hardev , Thibodeau, Stephen N. , Martin, Richard M. , Teixeira, Manuel R , Vega, Ana , Eeles, Rosalind A , John, Esther M , Donovan, Jenny L , Muir, Kenneth , Schleutker, Johanna , Travis, Ruth C , Pashayan, Nora , Lessel, Davor , Koutros, Stella , Martin, Richard M , Conti, David V , Batra, Jyotsna , Davey Smith, George , Zheng, Jie , Kote‐Jarai, Zsofia , Berndt, Sonja I. , Wiklund, Fredrik E. , Chanock, Stephen Jacob , Tangen, Catherine M. , Clements, Judith A. , Albanes, Demetrius , Wolk, Alicja , Cancel‐Tassin, Géraldine , Hamilton, Robert J , Ingles, Sue A. , Giles, Graham G. , Kogevinas, Manolis , Penney, Kathryn , Park, Jong Y. , Cybulski, Cezary , Brenner, Hermann , Neuhausen, Susan L. , Ruyck, Kim De , Razack, Azad Hassan Abdul , Khaw, Kay‐Tee , Cannon‐Albright, Lisa , Claessens, Frank

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | October 23, 2018 | Volume: 28 | Issue: 1 | Pages: 208-216

10.1158/1055-9965.epi-18-0079 | PMID 30352818 Get It

Abstract Background: Whether associations between circulating metabolites and prostate cancer are causal is unknown. We report on the largest study of metabolites and prostate cancer (2,291 cases and 2,661 controls) and appraise causality for a subset of the prostate cancer–metabolite associations using two-sample Mendelian randomization (MR). Methods: The case–control portion of the study was conducted in nine UK centers with men ages 50–69 years who underwent prostate-specific antigen screening for prostate cancer within the Prostate Testing for Cancer and Treatment (ProtecT) trial. Two data sources were used to appraise causality: a genome-wide association study (GWAS) of metabolites in 24,925 participants and a GWAS of prostate cancer in 44,825 cases and 27,904 controls within the Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL) consortium. Results: Thirty-five metabolites were strongly associated with prostate cancer (P &lt; 0.0014, multiple-testing threshold). These fell into four classes: (i) lipids and lipoprotein subclass characteristics (total cholesterol and ratios, cholesterol esters and ratios, free cholesterol and ratios, phospholipids and ratios, and triglyceride ratios); (ii) fatty acids and ratios; (iii) amino acids; (iv) and fluid balance. Fourteen top metabolites were proxied by genetic variables, but MR indicated these were not causal. Conclusions: We identified 35 circulating metabolites associated with prostate cancer presence, but found no evidence of causality for those 14 testable with MR. Thus, the 14 MR-tested metabolites are unlikely to be mechanistically important in prostate cancer risk. Impact: The metabolome provides a promising set of biomarkers that may aid prostate cancer classification.
Smooth muscle brain‐derived neurotrophic factor contributes to airway hyperreactivity in a mouse model of allergic asthma
Britt, Rodney D. , Wicher, Sarah A. , Manlove, L., Roesler, A.M., Fang, Yun-Hua, Roos, Carolyn M, Miller, Jordan D. , Prakash, Y. S. , Manlove, Logan J, Roesler, Anne, Roos, Carolyn, Prakash, Y S , Thompson, Michael A. , Smith, Leslie , Pabelick, Christina M. , Miller, Jordan

Mayo Clinic

The FASEB Journal | October 23, 2018 | Volume: 33 | Issue: 2 | Pages: 3024-3034

10.1096/fj.201801002r | PMID 30351991 Get It

ABSTRACT Recent studies have demonstrated an effect of neurotrophins, particularly brain‐derived neurotrophic factor (BDNF), on airway contractility [ via increased airway smooth muscle (ASM) intracellular calcium [Ca 2+ ] i ] and remodeling (ASM proliferation and extracellular matrix formation) in the context of airway disease. In the present study, we examined the role of BDNF in allergen‐induced airway inflammation using 2 transgenic models: 1 ) tropomyosin‐related kinase B (TrkB) conditional knockin (TrkBKI) mice allowing for inducible, reversible disruption of BDNF receptor kinase activity by administration of 1NMPP1, a PP1 derivative, and 2) smooth muscle‐specific BDNF knockout (BDNF fl/fl /SMMHCll Cre/0 ) mice. Adult mice were intranasally challenged with PBS or mixed allergen ( Altemaria alternata, Aspergillus fumigatus , house dust mite, and ovalbumin) for 4 wk. Our data show that administration of 1NMPP1 in TrkBKI mice during the 4‐wk allergen challenge blunted airway hyper‐responsiveness (AHR) and reduced fibronectin mRNA expression in ASM layers but did not reduce inflammation per se . Smooth muscle‐specific deletion of BDNF reduced AHR and blunted airway fibrosis but did not significantly alter airway inflammation. Together, our novel data indicate that TrkB signaling is a key modulator of AHR and that smooth muscle‐derived BDNF mediates these effects during allergic airway inflammation.—Britt, R. D., Jr., Thompson, M. A., Wicher, S. A., Manlove, L. J., Roesler, A., Fang, Y.‐H., Roos, C., Smith, L., Miller, J. D., Pabelick, C. M., Prakash, Y. S. Smooth muscle brain‐derived neurotrophic factor contributes to airway hyperreactivity in a mouse model of allergic asthma. FASEB J. 33, 3024–3034 (2019). www.fasebj.org
P3‐597: MEDIAL TEMPORAL LOBE NEURODEGENERATION OBSERVED IN WOMEN WHO UNDERWENT BILATERAL OOPHORECTOMY BEFORE THE ONSET OF MENOPAUSE
Tosakulwong, Nirubol , Lesnick, Timothy G. , Bailey, Kent R. , Lowe, Val J. , Petersen, Ronald C. , Miller, Virginia M. , Rocca, Walter A. , Zeydan, Burcu , Schwarz, Christopher G. , Senjem, Matthew L. , Smith, Carin Y. , Jack, Clifford R. , Mielke, Michelle M. , Kantarci, Kejal

Mayo Clinic

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_25 | Pages: No page available

10.1016/j.jalz.2018.06.1963 Get It

Cosmetic outcomes and quality of life in children with cardiac implantable electronic devices
Gist, Katja M. , Marino, Bradley S. , Palmer, Claire , Fish, Frank A. , Moore, Jeremy P. , Czosek, Richard J. , Cassedy, Amy , Law, Ian H. , Garnreiter, Jason M., Cannon, Bryan C. , Collins, Kathryn K. , Cannon, Bryan C , Law, Ian H , LaPage, Martin J

Mayo Clinic

Pacing and Clinical Electrophysiology | October 18, 2018 | Volume: 42 | Issue: 1 | Pages: 46-57

10.1111/pace.13522 | PMID 30334588 Get It

AbstractBackgroundAxillary implant location is an alternative implant location in patients for cardiac implantable electronic devices (CIEDs) for the purposes of improved cosmetic outcome. The impact from the patient's perspective is unknown. The purpose of this study was to compare scar perception scores and quality of life (QOL) in pediatric patients with axillary CIED implant location versus the standard infraclavicular approach.MethodsThis is a multicenter prospective study conducted at eight pediatric centers and it includes patients aged from 8 to 18 years with a CIED. Patients with prior sternotomy were excluded. Scar perception and QOL outcomes were compared between the infraclavicular and axillary implant locations.ResultsA total of 141 patients (83 implantable cardioverter defibrillator [ICD]/58 pacemakers) were included, 55 with an axillary device and 86 with an infraclavicular device. Patients with an ICD in the axillary position had better perception of scar appearance and consciousness. Patients in the axillary group reported, on average, a total Pediatric QOL Inventory score that was 6 (1, 11) units higher than the infraclavicular group, after adjusting for sex and race (P = 0.02).ConclusionsQOL is significantly improved in axillary in comparison to the infraclavicular CIED position, regardless of device type. Scar perception is improved in patients with ICD in the axillary position.
Follicular Dendritic Cell Sarcoma With NF2 Mutation
Karrs, Jeremiah , Gohlke, Amanda Lynn, Oliveira, André M. , Richard, Hope , Pavlick, Dean C. , Smith, Steven C. , Poklepovic, Andrew

Mayo Clinic

AJSP: Reviews and Reports | October 16, 2018 | Volume: 23 | Issue: 6 | Pages: 251-254

10.1097/pcr.0000000000000277 Get It

Abstract Follicular dendritic cell sarcoma (FDCS) is recognized as a diagnostically challenging neoplasm requiring rigorous exclusion of more common entities and high index of suspicion for diagnosis. Here, we report an aggressive case of FDCS arising in the mediastinum, which due to sampling limitations and the inherent difficulty of diagnosis required extensive workup with multiple samples prior to definitive classification. The patient was a 35-year-old woman who presented with progressive dyspnea and mediastinal mass on imaging studies. The initial sampling of the lesion had histologic features raising consideration of FDCS, but was too limited to allow definitive diagnosis, while progressing rapidly enough to require administration of chemotherapy even prior to classification. Repeat samples obtained via fine-needle aspiration and bronchoscopy enabled the diagnosis of FDCS, and high-throughput sequencing revealed apparently pathogenic NF2 mutations previously not reported in this disease. Unfortunately, the patient died of widely metastatic disease, which we comprehensively documented at autopsy. Together, these observations provide previously unreported insights into the end stage of this disease and experience relevant to its prospective recognition and workup.
Late-onset Lennox-Gastaut syndrome
Cascino, Gregory D. , Smith, Kelsey M. , Britton, Jeffrey W.

Mayo Clinic

Neurology Clinical Practice | October 15, 2018 | Volume: 8 | Issue: 5 | Pages: 397-402

10.1212/cpj.0000000000000527 | PMID 30564493 Get It

Loss of Ovarian Hormones and Accelerated Somatic and Mental Aging
Rocca, Walter A. , Rocca, Liliana Gazzuola , Shuster, Lynne T., Kirkland, James L. , Schafer, Marissa , Mielke, Michelle M. , Kantarci, Kejal , Miller, Virginia M. , Gazzuola Rocca, Liliana, Smith, Carin Y. , Grossardt, Brandon R. , Schafer, Marissa J, Mielke, Michelle M , Kantarci, Kejal , Schafer, Marissa J , Faubion, Stephanie S. , LeBrasseur, Nathan K. , Stewart, Elizabeth A.

Mayo Clinic

Physiology | October 10, 2018 | Volume: 33 | Issue: 6 | Pages: 374-383

10.1152/physiol.00024.2018 | PMID 30303778 Get It

Bilateral oophorectomy in premenopausal women is a unique condition causing the abrupt and premature loss of ovarian hormones, primarily estrogen. Bilateral oophorectomy causes an alteration of several fundamental aging processes at the cellular, tissue, organ, and system levels, leading to multimorbidity, frailty, and reduced survival. However, many questions remain unanswered.